HAMP and type 2 diabetes mellitus: In addition, the fact that participants with Type 2 diabetes and polycystic ovary syndrome had lower circulating hepcidin levels than control subjects suggests that inflammation is not the predominant factor regulating hepcidin levels in these individuals.